Brolamfetamine

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 581500

CAS#: 64638-07-9 (free base)

Description: Brolamfetamine, Dimethoxybromoamphetamine (DOB), also known as brolamfetamine and bromo-DMA, is a psychedelic drug and substituted amphetamine of the phenethylamine class of compounds.

Chemical Structure

img
Brolamfetamine
CAS# 64638-07-9 (free base)
Instruction

Theoretical Analysis

MedKoo Cat#: 581500
Name: Brolamfetamine
CAS#: 64638-07-9 (free base)
Chemical Formula: C11H16BrNO2
Exact Mass: 273.04
Molecular Weight: 274.158
Elemental Analysis: C, 48.19; H, 5.88; Br, 29.15; N, 5.11; O, 11.67

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Related CAS #: 29705-96-2 (HCl)   64638-07-9 (free base)   53581-53-6 (HBr)  

Synonym: Brolamfetamine; Brolamfetaminum; Brolanfetamin

IUPAC/Chemical Name: dl-2,5-Dimethoxy-4-bromoamphetamine

InChi Key: FXMWUTGUCAKGQL-UHFFFAOYSA-N

InChi Code: InChI=1S/C11H16BrNO2/c1-7(13)4-8-5-11(15-3)9(12)6-10(8)14-2/h5-7H,4,13H2,1-3H3

SMILES Code: NC(CC1=CC(OC)=C(Br)C=C1OC)C

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.03.00

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 274.16 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Ballesta S, Reymond G, Pozzobon M, Duhamel JR. Effects of MDMA Injections on the Behavior of Socially-Housed Long-Tailed Macaques (Macaca fascicularis). PLoS One. 2016 Feb 3;11(2):e0147136. doi: 10.1371/journal.pone.0147136. eCollection 2016. PubMed PMID: 26840064; PubMed Central PMCID: PMC4739726.

2: Gadegbeku B, Amoros E, Laumon B. Responsibility study: main illicit psychoactive substances among car drivers involved in fatal road crashes. Ann Adv Automot Med. 2011;55:293-300. PubMed PMID: 22105404; PubMed Central PMCID: PMC3256820.

3: Leviel V. Dopamine release mediated by the dopamine transporter, facts and consequences. J Neurochem. 2011 Aug;118(4):475-89. doi: 10.1111/j.1471-4159.2011.07335.x. Epub 2011 Jul 1. Review. PubMed PMID: 21644994.

4: Bertrand JB, Langlois JB, Bégou M, Volle J, Brun P, d'Amato T, Saoud M, Suaud-Chagny MF. Longitudinal MRI monitoring of brain damage in the neonatal ventral hippocampal lesion rat model of schizophrenia. Hippocampus. 2010 Feb;20(2):264-78. doi: 10.1002/hipo.20628. PubMed PMID: 19452521.

5: Bégou M, Brun P, Bertrand JB, Job D, Schweitzer A, D'Amato T, Saoud M, Andrieux A, Suaud-Chagny MF. Post-pubertal emergence of alterations in locomotor activity in stop null mice. Synapse. 2007 Sep;61(9):689-97. PubMed PMID: 17559095.

6: Miyatake R, Doi T, Date K, Naitoh T, Suwaki H. [Clinical study of BRON-L syrup (cough suppressant) abuse]. Nihon Arukoru Yakubutsu Igakkai Zasshi. 2002 Feb;37(1):67-74. Japanese. PubMed PMID: 11915306.

7: Nakahara Y, Kikura R. Hair analysis for drugs of abuse. XIX. Determination of ephedrine and its homologs in rat hair and human hair. J Chromatogr B Biomed Sci Appl. 1997 Oct 24;700(1-2):83-91. PubMed PMID: 9390717.